Entering text into the input field will update the search result below

Ultralife Q4 sales reduce 7% with decline in overall margins; shares are down ~10%

Feb. 07, 2019 10:40 AM ETUltralife Corporation (ULBI) StockBy: Vandana Singh, SA News Editor
  • Ultralife (NASDAQ:ULBI -10.4%) reports Q4 revenue declines 7% to $20.9M, primarily due to lower communications systems sales, partially offset by increase in Battery & Energy Products sale.
  • Battery & Energy Products sales is +8% to $18.2M, primarily due to 13% increase in commercial sales led by higher shipments to medical customers and 2% increase in government/defense sales.
  • Communications Systems sales declines 51% to $2.8M, due to due to modifications to production and initial shipment schedules under the $19M in delivery contracts received in October 2018 for the US Army.
  • The company has a backlog of over $50M, +30% Y/Y.
  • Gross margin declines ~320bps to 27.3% primarily due to sales mix; operating is down ~400bps to 5.1%; adj. EBITDA margin improves marginally to 11.4%
  • Previously: Ultralife reports Q4 results (Feb. 7)

Recommended For You

More Trending News

About ULBI Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ULBI--
Ultralife Corporation